Kiora Pharma Details 2024 Executive Pay
Ticker: KPHMW · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1372514
| Field | Detail |
|---|---|
| Company | Kiora Pharmaceuticals Inc (KPHMW) |
| Form Type | DEF 14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement
Related Tickers: KPRX
TL;DR
KPRX dropped executive pay details for 2024, showing who got what.
AI Summary
Kiora Pharmaceuticals Inc. (KPRX) filed a DEF 14A on April 30, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. Key individuals compensated include Brian M. Strem, Ph.D., Eric J. Daniels, M.D., M.B.A., and Melissa Tosca, CPA. The filing also references compensation for 'First PEO' and 'Second PEO' for the years 2022, 2023, and 2024.
Why It Matters
This filing provides transparency into how Kiora Pharmaceuticals compensates its top executives, which can influence investor perception and corporate governance.
Risk Assessment
Risk Level: low — This is a routine proxy statement detailing executive compensation and does not introduce new financial risks.
Key Players & Entities
- Kiora Pharmaceuticals Inc. (company) — Filer
- Brian M. Strem, Ph.D. (person) — Member of Board of Directors
- Eric J. Daniels, M.D., M.B.A. (person) — Member of Board of Directors
- Melissa Tosca, CPA (person) — Member of Board of Directors
- First PEO (person) — Executive
- Second PEO (person) — Executive
FAQ
What is the filing date of this DEF 14A?
The filing date is April 30, 2025.
What fiscal year does this filing primarily cover regarding executive compensation?
The filing primarily covers the fiscal year ending December 31, 2024.
Who are some of the named individuals compensated by Kiora Pharmaceuticals?
The filing names Brian M. Strem, Ph.D., Eric J. Daniels, M.D., M.B.A., and Melissa Tosca, CPA, as members.
What was Kiora Pharmaceuticals' former name?
Kiora Pharmaceuticals Inc.'s former name was Eyegate Pharmaceuticals Inc.
In which state was Kiora Pharmaceuticals incorporated?
Kiora Pharmaceuticals Inc. was incorporated in Delaware (DE).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 by Brian M. Strem, Ph.D. regarding KIORA PHARMACEUTICALS INC (KPHMW).